139 related articles for article (PubMed ID: 31990066)
21. MicroRNA-342 targets Cofilin 1 to suppress the growth, migration and invasion of human breast cancer cells.
Liu C; Xing H; Luo X; Wang Y
Arch Biochem Biophys; 2020 Jul; 687():108385. PubMed ID: 32335050
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells.
Fu H; Wen JF; Hu ZL; Luo GQ; Ren HZ
Pathology; 2009; 41(7):655-60. PubMed ID: 20001345
[TBL] [Abstract][Full Text] [Related]
23. Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells.
Karp M; Karczmarczyk A; Bojarska-Junak A; Purkot J; Chojnacki M; ZajĄc M; Korpysz M; Tomczak W; Hus M; Morawska M; Giannopoulos K
Anticancer Res; 2020 Nov; 40(11):6327-6335. PubMed ID: 33109570
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
25. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of EPCR inhibits the proliferation and migration of human gastric cancer cells via the ERK1/2 pathway in a PAR-1-dependent manner.
Wang Q; Yang H; Zhuo Q; Xu Y; Zhang P
Oncol Rep; 2018 Apr; 39(4):1843-1852. PubMed ID: 29484413
[TBL] [Abstract][Full Text] [Related]
27. EWS represses cofilin 1 expression by inducing nuclear retention of cofilin 1 mRNA.
Huang L; Kuwahara I; Matsumoto K
Oncogene; 2014 Jun; 33(23):2995-3003. PubMed ID: 23831569
[TBL] [Abstract][Full Text] [Related]
28. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
29. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target.
Mao ZB; Zhang JF; Xu Z; Zhu HJ; Zhang JG; Pan ZP; Xiao F; Yang JL
J Dig Dis; 2009 Nov; 10(4):272-85. PubMed ID: 19906106
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression.
Zhang J; Xu J; Dong Y; Huang B
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29899167
[TBL] [Abstract][Full Text] [Related]
31. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
[TBL] [Abstract][Full Text] [Related]
33. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
34. LncRNA‑NEF is involved the regulation of gastric carcinoma cell proliferation by targeting RUNX1.
Wang X; Jiang X; Zhou L; Wang Z; Huang H; Wang M
Mol Med Rep; 2019 Mar; 19(3):2051-2056. PubMed ID: 30664208
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
36. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
37. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
38. Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer.
Peng H; Yang H; Song L; Zhou Z; Sun J; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
J Exp Clin Cancer Res; 2016 Mar; 35():57. PubMed ID: 27029190
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.
Yin J; Cui Y; Li L; Ji J; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4489-4497. PubMed ID: 28739744
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
Liang X; Shi H; Yang L; Qiu C; Lin S; Qi Y; Li J; Zhao A; Liu J
Br J Cancer; 2017 Mar; 116(7):903-911. PubMed ID: 28222070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
